Condition
Neuropathic Pain Management
Total Trials
3
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
3Total
Not Applicable (3)
Trial Status
Not Yet Recruiting2
Enrolling By Invitation1
Clinical Trials (3)
Showing 3 of 3 trials
NCT07377409Not ApplicableNot Yet RecruitingPrimary
Beneficial Effects of Supplementation With CRONILIEF™ (Palmitoylethanolamide Phospholipids) in Diabetic Subjects With Neuropathic Pain.
NCT07054450Not ApplicableEnrolling By Invitation
Assessment and Rehabilitation in Cervical Radiculopathy
NCT06029075Not ApplicableNot Yet RecruitingPrimary
tACS for Neuropathic Pain Management After SCI
Showing all 3 trials